Boston Microfluidics is focused on solving next generation blood collection: Consumer driven, remote self-collection, and even remote testing. The company develops well designed medical device products that make it easier for patients, and their healthcare providers, to connect to their health.
NTx develops a cell-free process to produce biologics of high purity, stability, and low cost. The firm has the world’s first fully recombinant cell-free system based on thermophile strains and using continuous flow bioreactors.
Adaptive Surface Technologies is a high-tech materials company that creates fully slippery coatings for multiple industries including manufacturing, marine vessels, and medical devices.
Niron is developing innovative advanced magnetic materials for high performance, low cost permanent magnets.
GelSight develops portable, non-destructive elastomeric 3D imaging systems used to improve quality control processes in aerospace, automotive and other high-value industries.
TeraPore Technologies develops high-permeability, high-resolution membrane nanofiltration systems for bioprocessing and other applications.
Pivotal Systems provides best-in-class monitoring and process control technology for the semiconductor manufacturing industry.
NUBURU is manufacturing the world’s first high-power blue laser for metal cutting, welding, and additive manufacturing.
6K (formerly Amastan Technologies) uses proprietary advanced plasma processing and industrial systems to create materials that are enabling the next-generation of commercial and consumer products. 6K focuses on developing critical materials used to manufacture silicon wafers, LED lighting, powders for industrial 3D printing, advanced battery technologies, and thermal coatings.
Liquid Instruments develops the Moku:Lab, a software-reconfigurable device for real-time signal processing that brings a new level of flexibility in the lab, in the field, or on the production line.
BioFlyte is commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats.
Anzu Partners is an investment firm that focuses on breakthrough industrial and life sciences technology companies. We team with entrepreneurs to develop and commercialize technological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations.
Anzu manages approximately $350 million in capital commitments, across two venture funds and a revenue-based investing (“RBI”) fund. The venture capital funds focus on investments in early-stage companies, ranging from pre-revenue to post-commercialization, primarily in the US and Canada with selective investments in Europe and Asia Pacific. RBI provides capital through a non-dilutive preferred share vehicle to post-revenue companies, offering an alternative to traditional venture and debt financing, that supports post-revenue companies across North America, Europe, and Asia Pacific.
We have a robust team of investment, technical, and operational professionals to drive results for our portfolio companies and investors. Anzu’s principals have 60+ years of combined experience as global investors and consultants, and have built a commercial support network spanning key industrial markets across the globe.
We focus on four key areas:
Robotics and Advanced Tools
Bioprocessing for Therapeutics
Synthetic Biology and Biomolecular Assembly
Nanomaterials and Electronic Materials
Biomaterials and Organic Materials
High Value New Consumables
Novel Fabrication Methods
Measurement & Monitoring
Microelectromechanical Systems Sensing
New Process Control and Automation Needs
Molecular Diagnostics & Characterization
Edge Computing and IoT
Computer-Aided Engineering Simulation
Artificial Intelligence and Data Analytics
Electronic Design Automation
Quantum and Computational Chemistry